Based on 2 analysts giving stock ratings to Senti Biosciences Inc in the past month.
In the current month, SNTI has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SNTI average Analyst price target in the last month is 10.500.
Based on analysts' estimates, SNTI EPS is projected to reach -0.295 in FY2026Q3, following reported EPS of -0.409 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.41, while Senti Biosciences IncSNTI's earnings per share (EPS) for the previous quarter was USD -0.14. EPS for the next quarter is expected at USD -0.29.